ALX3
protein-codingALX homeobox 3, the group of PRD class homeoboxes and pseudogenes
Gene summary
This gene encodes a nuclear protein with a homeobox DNA-binding domain that functions as a transcriptional regulator involved in cell-type differentiation and development. Preferential methylation of this gene's promoter is associated with advanced-stage neuroblastoma tumors. [provided by RefSeq, Jul 2008]
- FND
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~10.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0007636
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0007636
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0007636
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0007636
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0007636
Submitter: ClinGen
ALX3 has been repeatedly described in association with autosomal recessive Frontonasal dysplasia 1 also known as Frontorhiny. Frontonasal dysplasia 1 is characterized by having a distinctive facial appearance with hypertelorism, broad nasal bridge, short nasal ridge, splayed nasal bones with bifid nasal tip, broad columella that attaches to the lip above the alae, widely separated slit-like nares, long philtrum with prominent bilateral swellings, and midline notch in the upper lip and alveolus. At least 1 missense, 2 nonsense, 1 splice acceptor, 1 deletion mutations have been reported in at least 5 probands from 4 publications (PMIDs: 19409524, 22106187, 29215096, 34098755) This gene disease association is also supported by experimental evidence including expression data and an animal model (PMID:20534379) . In summary ALX3 is definitively associated with autosomal recessive Frontonasal dysplasia 1. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Craniofacial Malformations Gene Curation Expert Panel on 10/13/2022. (SOP Version 9)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ALX3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006492.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 13 | 2 | 15 | |||
| missense | 3 | 66 | 3 | 72 | ||
| nonsense | 4 | 4 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 9 | 1 | 67 | 16 | 2 | 95 |
Highest pathogenic variant AF is 0.000003717403
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006483.2 | 4 | MANE Select | |
| Ensembl | ENSP00000497310.1 | 4 | MANE Select | |
| Ensembl | ENSP00000497035.1 | 3 | Standard | |
| Ensembl | ENSP00000497035.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- regulation of transcription by RNA polymerase II
- pattern specification process
- embryonic forelimb morphogenesis
- embryonic hindlimb morphogenesis
- regulation of apoptotic process
Molecular Function
- RNA polymerase II regulatory region sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- sequence-specific DNA binding
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000369792
- Coding exons
- 4
- Length
- 10707
- Individuals with no LoFs
- 125740
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 7
- Defined
- 125747
- p
- 0.0000278
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.446 | 151 | 167 | 0.903 | 0.0000103 | 2178 |
| Missense (PolyPhen) | 54 | 78.396 | 0.68881 | 805 | ||
| Synonymous | 0.475 | 63 | 68.0 | 0.927 | 0.00000385 | 752 |
| Loss of Function | 1.51 | 4 | 8.87 | 0.451 | 4.64e-7 | 122 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000035 | 0.000035 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcriptional regulator with a possible role in patterning of mesoderm during development. {ECO:0000250}.;
- Disease
- DISEASE: Frontonasal dysplasia 1 (FND1) [MIM:136760]: The term frontonasal dysplasia describes an array of abnormalities affecting the eyes, forehead and nose and linked to midfacial dysraphia. The clinical picture is highly variable. Major findings include true ocular hypertelorism; broadening of the nasal root; median facial cleft affecting the nose and/or upper lip and palate; unilateral or bilateral clefting of the alae nasi; lack of formation of the nasal tip; anterior cranium bifidum occultum; a V-shaped or widow's peak frontal hairline. {ECO:0000269|PubMed:19409524}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0999
Intolerance Scores
- LoFtool
- 0.150
- RVIS EVS
- -0.25
- RVIS percentile EVS
- 35.75
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.467
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |